Home NDC 0363-0227 Aspirin
Product NDC 0363-0227
11-digit product format 003630227
Labeler code 0363
Product ID 0363-0227_dc59a437-ff45-4022-a5da-41f415cd00a4
Type HUMAN OTC DRUG
Nonproprietary name Aspirin
Dosage form TABLET, DELAYED RELEASE
Route ORAL
Labeler Walgreen Company
Application M013
Marketing category OTC MONOGRAPH DRUG
Marketing start 1992-12-14
Substance ASPIRIN
Active strength 325 mg/1
Pharmacologic classes Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 12 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Aspirin
Brand name suffix Enteric Coated, Regular Strength
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ASPIRIN 325 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination R16CO5Y76E Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 198467 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0363-0227-14 AspirinEnteric Coated, Regular Strength 500 in 1 BOTTLE, PLASTIC TABLET, DELAYED RELEASE 500 19 0363-0227-57 AspirinEnteric Coated, Regular Strength 1 in 1 CARTON TABLET, DELAYED RELEASE 1 19 0363-0227-57 AspirinEnteric Coated, Regular Strength 125 in 1 BOTTLE, PLASTIC TABLET, DELAYED RELEASE 125 19
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded ASPIRIN ACTIVE INGREDIENT R16CO5Y76E ASPIRIN ENTERIC COATED, REGULAR STRENGTH (ASPIRIN) TABLET, COATED [WALGREEN CO.] 4 ASPIRIN ACTIVE MOIETY R16CO5Y76E ASPIRIN ENTERIC COATED, REGULAR STRENGTH (ASPIRIN) TABLET, COATED [WALGREEN CO.] 4 D&C YELLOW NO. 10 INACTIVE INGREDIENT 35SW5USQ3G ASPIRIN ENTERIC COATED, REGULAR STRENGTH (ASPIRIN) TABLET, COATED [WALGREEN CO.] 4 FD&C YELLOW NO. 6 INACTIVE INGREDIENT H77VEI93A8 ASPIRIN ENTERIC COATED, REGULAR STRENGTH (ASPIRIN) TABLET, COATED [WALGREEN CO.] 4 FERROSOFERRIC OXIDE INACTIVE INGREDIENT XM0M87F357 ASPIRIN ENTERIC COATED, REGULAR STRENGTH (ASPIRIN) TABLET, COATED [WALGREEN CO.] 4 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO ASPIRIN ENTERIC COATED, REGULAR STRENGTH (ASPIRIN) TABLET, COATED [WALGREEN CO.] 4 POLYDEXTROSE INACTIVE INGREDIENT VH2XOU12IE ASPIRIN ENTERIC COATED, REGULAR STRENGTH (ASPIRIN) TABLET, COATED [WALGREEN CO.] 4 POLYETHYLENE GLYCOLS INACTIVE INGREDIENT 3WJQ0SDW1A ASPIRIN ENTERIC COATED, REGULAR STRENGTH (ASPIRIN) TABLET, COATED [WALGREEN CO.] 4 Polyvinyl Acetate Phthalate INACTIVE INGREDIENT 58QVG85GW3 ASPIRIN ENTERIC COATED, REGULAR STRENGTH (ASPIRIN) TABLET, COATED [WALGREEN CO.] 4 PROPYLENE GLYCOL INACTIVE INGREDIENT 6DC9Q167V3 ASPIRIN ENTERIC COATED, REGULAR STRENGTH (ASPIRIN) TABLET, COATED [WALGREEN CO.] 4 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 ASPIRIN ENTERIC COATED, REGULAR STRENGTH (ASPIRIN) TABLET, COATED [WALGREEN CO.] 4 SODIUM ALGINATE INACTIVE INGREDIENT C269C4G2ZQ ASPIRIN ENTERIC COATED, REGULAR STRENGTH (ASPIRIN) TABLET, COATED [WALGREEN CO.] 4 SODIUM BICARBONATE INACTIVE INGREDIENT 8MDF5V39QO ASPIRIN ENTERIC COATED, REGULAR STRENGTH (ASPIRIN) TABLET, COATED [WALGREEN CO.] 4 STEARIC ACID INACTIVE INGREDIENT 4ELV7Z65AP ASPIRIN ENTERIC COATED, REGULAR STRENGTH (ASPIRIN) TABLET, COATED [WALGREEN CO.] 4 TALC INACTIVE INGREDIENT 7SEV7J4R1U ASPIRIN ENTERIC COATED, REGULAR STRENGTH (ASPIRIN) TABLET, COATED [WALGREEN CO.] 4 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP ASPIRIN ENTERIC COATED, REGULAR STRENGTH (ASPIRIN) TABLET, COATED [WALGREEN CO.] 4 TRIACETIN INACTIVE INGREDIENT XHX3C3X673 ASPIRIN ENTERIC COATED, REGULAR STRENGTH (ASPIRIN) TABLET, COATED [WALGREEN CO.] 4 TRIETHYL CITRATE INACTIVE INGREDIENT 8Z96QXD6UM ASPIRIN ENTERIC COATED, REGULAR STRENGTH (ASPIRIN) TABLET, COATED [WALGREEN CO.] 4
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0363-0227 ASPIRIN ENTERIC COATED, REGULAR STRENGTH (ASPIRIN) TABLET, DELAYED RELEASE [WALGREEN COMPANY] 17 Current NDC, Legacy NDC, 3 package rows 20240825_5e1484d3-5be1-40da-a3bf-fb19f7d27d45.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 47 of 79 · 1,576 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Pain Relief ACETAMINOPHEN DISCOUNT DRUG MART 97f78c4a-9d0d-4fe1-8b2b-d5f8ab939ac4 2025-03-07 Warnings Exact identifier application number: M013 Redicare Non-Aspirin 500mg REDICARE NON-ASPIRIN, ACETAMINOPHEN 500MG Redicare LLC 2f229898-1777-732c-e063-6394a90a76bc 2025-03-04 Warnings, Adverse reactions Exact identifier application number: M013 Major Extra Strength Acetaminophen Liquid ACETAMINOPHEN Major Pharmaceuticals 2f3af4dd-45d5-87b4-e063-6294a90ab3cc 2025-02-28 Warnings Exact identifier application number: M013 LOW DOSE ASPIRIN ASPIRIN NCS HealthCare of KY, LLC dba Vangard Labs ed9a71d6-a56e-416a-bb89-6d41307efc5a 2025-02-27 Warnings Exact identifier application number: M013 Aspirin ASPIRIN PD-Rx Pharmaceuticals, Inc. 77429b7f-78e4-42c0-8679-ae8da1748848 2025-02-26 Warnings Exact identifier application number: M013 AeroTab Non-Aspirin ACETAMINOPHEN 500MG ES Aero Healthcare faa3a4ef-3c70-06ca-e053-6394a90a512d 2025-02-26 Warnings Exact identifier application number: M013 Bufferin Regular Strength Pain Relief ASPIRIN Genomma Lab USA 3543b2bf-1062-468a-a5dc-eabb2408af8c 2025-02-25 Warnings Exact identifier application number: M013 Calmour Childrens Acetaminophen Strips Chewable ACETAMINOPHEN ORAL CHEWABLE 80 MG Calmour ae47b027-4f29-45bb-a8bd-812978932835 2025-02-22 Warnings Exact identifier application number: M013 Infants TYLENOL ACETAMINOPHEN Kenvue Brands LLC f9de7c2f-016b-4f40-8b5e-141ad194be97 2025-02-20 Warnings Exact identifier application number: M013 Genexa Acetaminophen PM Extra Strength ACETAMINOPHEN Genexa Inc. d82cf6f3-a291-ca2b-e053-2a95a90a6de1 2025-02-20 Warnings Exact identifier application number: M013 Childrens Acetaminophen ACETAMINOPHEN Advagen Pharma Limited 8b9456c9-a56b-4748-adb8-c66d6bf072e8 2025-02-19 Warnings Exact identifier application number: M013 Genexa Childrens Acetaminophen ACETAMINOPHEN Genexa Inc. d89fd9d8-d88e-3968-e053-2a95a90afc5f 2025-02-19 Warnings Exact identifier application number: M013 Acetaminophen ACETAMINOPHEN Precision Dose, Inc. debfa787-7a48-48b5-94b0-612820524032 2025-02-19 Warnings Exact identifier application number: M013 Acetaminophen ACETAMINOPHEN Precision Dose, Inc. b16e5dcf-b290-4ff2-a150-4b875647ec9a 2025-02-19 Warnings Exact identifier application number: M013 TYLENOL Extra Strength ACETAMINOPHEN Kenvue Brands LLC bb6533e5-e6a9-488c-b8ab-a6a06e87ede9 2025-02-18 Warnings Exact identifier application number: M013 TYLENOL Extra Strength ACETAMINOPHEN Kenvue Brands LLC c830320e-72ba-48ff-a4cd-250ac5650bf0 2025-02-18 Warnings Exact identifier application number: M013 Aspirina Caplets ASPIRIN Bayer HealthCare LLC. 2e6f5ba8-8e8b-6059-e063-6394a90adcd5 2025-02-18 Warnings Exact identifier application number: M013 Acetaminophen ACETAMINOPHEN PD-Rx Pharmaceuticals, Inc. da7d95af-6583-429d-8d04-e0424f32e9ad 2025-02-17 Warnings Exact identifier application number: M013 GOODYS Mental Alert ASPIRIN AND CAFFEINE Medtech Products Inc. 31ef6d07-d314-4d09-abcd-389ba66cbcc5 2025-02-17 Warnings Exact identifier application number: M013 Aspirin 81 mg ASPIRIN Asclemed USA, Inc. 878dab20-668b-4d7a-a5f8-794a587564d5 2025-02-13 Warnings Exact identifier application number: M013
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 0363-0227-14 00363022714 500 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (0363-0227-14) 1992-12-14 0000-00-00 No No Current 0363-0227-57 00363022757 1 in 1 CARTON Historical